Simvastatin Added to Escitalopram in Obese Patients With Major Depression: A Rigorous RCT Shows No Antidepressant Benefit Despite Improved Cardiometabolic Markers
Posted inCardiology Clinical Updates Diabetes & Endocrinology news Psychiatry Specialties

Simvastatin Added to Escitalopram in Obese Patients With Major Depression: A Rigorous RCT Shows No Antidepressant Benefit Despite Improved Cardiometabolic Markers

A multicenter double-blind RCT (n=160) found that 12 weeks of simvastatin (40 mg) added to escitalopram did not improve depressive symptoms versus placebo, although LDL, total cholesterol, and CRP were reduced.
Blackcurrant Anthocyanins Improve Postprandial Vascular Function and Platelet Reactivity: Acute Crossover Trial Highlights Metabolites Linked to Benefit
Posted inCardiology Clinical Updates Family Medicine & Nutrition news Specialties

Blackcurrant Anthocyanins Improve Postprandial Vascular Function and Platelet Reactivity: Acute Crossover Trial Highlights Metabolites Linked to Benefit

In a randomized, double‑blind crossover trial, a 200 mL anthocyanin‑rich blackcurrant beverage (≈711 mg anthocyanins) taken with a high‑fat meal improved flow‑mediated dilation and reduced agonist‑induced platelet aggregation and IL‑8 over 6 hours in healthy middle‑aged adults; specific circulating phenolic metabolites correlated with the responses.